Approvals/HSA/MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL

Approved

THERAPEUTIC

MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL

Approval Date: May 4, 2016
Approval ID: 835a6320b32a97d5
Company: ACS DOBFAR S.P.A. (PRIMARY AND SECONDARY PACKAGING) - ITALYACS DOBFAR SPA 2: ADDETTA SITE (DP INTERMEDIATE) (ITALY)
Type: Therapeutic

Approval Id: 835a6320b32a97d5
Drug Name: MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL
Product Name: MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL
Approval Number: SIN15003P
Approval Date: 2016-05-04
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder: FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: J01DH02
Atc Item Name: meropenem
Pharma Manufacturer Name: FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path: /organization/fresenius-kabi-singapore-pte-ltd

Meropenem Trihydrate 1140mg equivalent to anhydrous Meropenem

1000mg/vial

MEROPENEM TRIHYDRATE 1,140 MG EQUIVALENT TO ANHYDROUS MEROPENEM

1,000 MG/VIAL

Approved

Agency

HSA

Country

🇸🇬

Approval Date

May 4, 2016

Approval ID

835a6320b32a97d5

Type

Therapeutic